China Universal Asset Management Company’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Buy |
9,261
+797
| +9% | +$10.9K | 0.01% | 344 |
|
|
2025
Q1 | $93.6K | Sell |
8,464
-484
| -5% | -$5.35K | 0.01% | 362 |
|
|
2024
Q4 | $95.3K | Buy |
8,948
+848
| +10% | +$9.03K | 0.01% | 396 |
|
|
2024
Q3 | $103K | Buy |
8,100
+3,856
| +91% | +$49K | 0.01% | 355 |
|
|
2024
Q2 | $71.2K | Sell |
4,244
-1,659
| -28% | -$27.8K | 0.01% | 326 |
|
|
2024
Q1 | $88.5K | Buy |
5,903
+2,328
| +65% | +$34.9K | 0.01% | 383 |
|
|
2023
Q4 | $53.6K | Buy |
3,575
+2,801
| +362% | +$42K | 0.01% | 365 |
|
|
2023
Q3 | $10.8K | Buy |
774
+467
| +152% | +$6.54K | ﹤0.01% | 340 |
|
|
2023
Q2 | $3.18K | Sell |
307
-6
| -2% | -$62 | ﹤0.01% | 405 |
|
|
2023
Q1 | $2.89K | Buy |
313
+79
| +34% | +$730 | ﹤0.01% | 416 |
|
|
2022
Q4 | $2.08K | Buy |
234
+21
| +10% | +$186 | ﹤0.01% | 370 |
|
|
2022
Q3 | $2K | Buy |
+213
| New | +$2K | ﹤0.01% | 361 |
|